The contributions of paul ehrlich to pharmacology: A tribute on the occasion of the centenary of his nobel prize

Pharmacology

Volumn 82, Issue 3, 2008, Pages 171-179

  Bosch, Fèlix ^a,b   Rosich, Laia ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b Esteve Foundation   (Spain)

Author keywords

Animal experimentation; Arsenicals; Arsphenamine; Chemotherapy; Dyes; Paul Ehrlich; Side chain theory; Syphilis; Therapeutic pharmacology

Indexed keywords

ANTIINFECTIVE AGENT; ARSACETIN; ARSANILIC ACID; ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; ARSENOPHENOL; ARSENOPHENYLGLYCINE; ARSPHENAMINE; BISMUTH; DIPHTHERIA ANTIBODY; MELARSOPROL; MERCURY; METHYLENE BLUE; NEOARSPHENAMINE; OXOPHENARSINE; QUININE; SPIRASYL; SULFAMIDOCHRYSOIDINE; TETANUS ANTIBODY; TRYPAN BLUE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; AWARDS AND PRIZES; CHEMICAL STRUCTURE; CHEMORECEPTOR; DRUG HYPERSENSITIVITY; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; LIFE EVENT; NAUSEA; NONHUMAN; PHARMACOLOGICAL SCIENCE; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SYPHILIS; VOMITING;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DESIGN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; NOBEL PRIZE; PHARMACOLOGY;

EID: 48449087282     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149583     Document Type: Review

References (33)

1. Official Website of the Nobel Foundation. Stockholm, 2008. http://nobelprize.org (accessed May 5, 2008).
2. Rubin RP: A brief history of great discoveries in pharmacology: in celebration of the centennial anniversary of the founding of the American Society of Pharmacology and Experimental Therapeutics. Pharmacol Rev 2007;59:289-359.
3. Kaufmann SHE: Paul Ehrlich: founder of chemotherapy. Nat Rev Drug Discov 2008;7:373.
4. Silverman M: Kill the Germs! Lister to Ehrlich to 205. Magic in a Bottle. New York, MacMillan, 1942, pp 134-168.
5. Mann J: The Elusive Magic Bullet. The Search for the Perfect Drug. New York, Oxford University Press, 1999, pp 1-209.
6. Kasten FH: Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy. Biotech Histochem 1996;71:2-37.
7. Venita J: A portrait of history: Paul Ehrlich. Arch Pathol Lab Med 2001;125:724.
8. Crivellato E, Beltrami CA, Mallardi F, Ribatti D: Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br J Haematol 2003;123:19-21.
9. Riethmiller S: From Atoxyl to Salvarsan: searching for the magic bullet. Chemotherapy 2005;51:234-242.
10. Paul Ehrlich. Langen, Paul-Ehrlich-Institut. http://www.pei.de/cln_046/ nn_162438/EN/institute-en/paul-ehrlich-en/paul-ehrlichnode-en.html?__nnn=true (accessed May 5, 2008).
11. Parascandola J: The theoretical basis of Paul Ehrlich's chemotherapy. J Hist Med Allied Sci 1981;36:19-43.
12. Kristiansen JE: Dyes, antipsychotic drugs, and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich. Dan Med Bull 1989;36:178-185.
13. Winau F, Westphal O, Winau R: Paul Ehrlich - In search of the magic bullet. Microbes Infect 2004;6:786-789.
14. Schwartz RS: Paul Ehrlich's magic bullets. N Engl J Med 2004;350:1079-1080.
15. Weatheral M: In Search of a Cure. New York, Oxford University Press, 1999.
16. Witkop B: Paul Ehrlich and his magic bullets - Revisited. Proc Am Philos Soc 1999;143:540-557.
17. Bennett MR: The concept of transmitter receptors: 100 years on. Neuropharmacology 2000;39:523-546.
18. Akatsu S, Noguchi H: The drug-fastness of spirochetes to arsenic, mercurial, and iodide compounds in vitro. J Exp Med 1917;25:349-362.
19. Krantz JC Jr: Paul Ehrlich and 'The Magic Bullet', Arsphenamine. Historical Medical Classics Involving New Drugs. Baltimore, Williams & Wilkins, 1974, pp 51-57.
20. Felsenfeld O: K. Shiga, bacteriologist. Science 1957;126:113.
21. Sneader W: Drug Discovery: A History. Chichester, Wiley, 2005.
22. Jolliffe DM: A history of the use of arsenicals in man. J R Soc Med 1993;86:287-289.
23. Drews J: Paul Ehrlich: magister mundi. Nat Rev Drug Discov 2004;3:797-801.
24. Gensini GF, Conti AA, Lippi D: The contributions of Paul Ehrlich to infectious disease. J Infect 2007;54:221-224.
25. Marlow FW Jr: Syphilis then and now. JAMA 1974;230:1320-1321.
26. Jaouen G, Beck W, McGlinchey MJ: A Novel Field of Research: Bioorganometallic Chemistry, Origins, and Founding Principles. Weinheim, Wiley-VCH, 2006, pp 1-37.
27. Montes J, Cueva J: Ehrlich, su vida y su obra. Alergia 1967;15:29-42.
28. Cowley AH, Lasch JG, Norman NC, Pakulski M: Synthesis and structure of a diarsene: the first compound with an unsupported arsenic-arsenic double bond. J Am Chem Soc 1983;105:5506-5507.
29. Lloyd NC, Morgan H, Nicholson BK, Ronimus RS: The composition of Ehrlich's salvarsan: resolution of a century-old debate. Angew Chem Int Ed Engl 2005;44:941-944.
30. Raju TNK: The Nobel chronicles. 1908: Elie Metchnikoff (1845-1916), Paul Ehrlich (1854-1915). Lancet 1998;352:661.
31. Jacobs MS: Paul Ehrlich and his relation to modern chemotherapy. Bull Hist Med 1940;8:956-964.
32. Silverstein AM: Paul Ehrlich, archives and the history of immunology. Nat Immunol 2005;6:639.
33. Cowen DL, Segelman AB: Antibiotics in Historical Perspective. New Jersey, Merck Sharp & Dohme, 1981.